BioinformaticsLife SciencesPeer-reviewed
Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinases
Anindita Bhattacharjee, Arka Bagchi, Solanki Sarkar…·Arunima Biswas
This study identifies sorafenib and imatinib as potential anti-leishmanial drugs by targeting Leishmania MAP kinases, showing anti-proliferative effects and reduced parasitic burden.
15 citationstop 3%